Regulatory T cells as novel cell-based therapy for ischemic stroke

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Ischemic stroke is a major global health concern, often worsened by excessive immune responses.
• Regulatory T (Treg) cells, with their immunosuppressive functions, are key to controlling post-stroke inflammation.
• Emerging research indicates Treg cells also promote recovery by reducing harmful astrogliosis and enhancing myelination.

Purpose of the Study:

• To review current knowledge on Treg cell roles in ischemic stroke.
• To focus on the understudied CD8+ Treg cell subset.
• To explore Treg cell mechanisms and clinical translation challenges.

Main Methods:

• Literature review of Treg cell function in ischemic stroke.
• Analysis of Treg cell activation, expansion, recruitment, and function.
• Examination of CD8+ Treg cell specific roles.

Main Results:

• Treg cells modulate both acute and chronic inflammatory responses post-stroke.
• CD8+ Treg cells represent a significant, yet overlooked, component of the Treg response.
• Treg cells influence neuroinflammation, astrogliosis, and promote neural repair mechanisms.

Conclusions:

• Treg cells are critical for ischemic stroke pathogenesis and recovery.
• Further research into CD8+ Treg cells is warranted.
• Overcoming challenges in Treg cell therapy is crucial for clinical application in stroke treatment.